Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Covalon Technologies Ltd. (CVALF : OTC)
 
 • Company Description   
Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies. The company's patented technologies, product and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Its technologies are used to prevent, detect and manage medical conditions in specialty areas such as infection control, vascular access, surgical procedures, advanced wound care and medical device coatings. Covalon Technologies Ltd. is based in Mississauga, Canada.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.17 Daily Weekly Monthly
20 Day Moving Average: 1,114 shares
Shares Outstanding: 27.62 (millions)
Market Capitalization: $32.24 (millions)
Beta: 0.54
52 Week High: $2.32
52 Week Low: $1.16
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -1.06% -1.14%
12 Week -13.52% -14.38%
Year To Date -5.85% -6.34%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1660 Tech Avenue Unit 5
-
Mississauga,A6 L4W 5S7
CAN
ph: 905-568-8400
fax: -
investors@covalon.com http://www.covalon.com
 
 • General Corporate Information   
Officers
Brent Ashton - Chief Executive Officer
Abe Schwartz - Chairman
Kim Crooks - Chief Operating Officer
Katie Martinovich - Chief Financial Officer
Greg Leszczynski - Vice President

Peer Information
Covalon Technologies Ltd. (ABMD)
Covalon Technologies Ltd. (DMDS)
Covalon Technologies Ltd. (CPWY.)
Covalon Technologies Ltd. (EQUR)
Covalon Technologies Ltd. (ECIA)
Covalon Technologies Ltd. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 22282D302
SIC: 8000
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/20/26
Share - Related Items
Shares Outstanding: 27.62
Most Recent Split Date: (:1)
Beta: 0.54
Market Capitalization: $32.24 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/20/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 23.35
PEG Ratio: -
Price Ratios
Price/Book: 1.46
Price/Cash Flow: 14.87
Price / Sales: 1.37
EPS Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -2.91%
vs. Previous Quarter: 4.31%
ROE
12/31/25 - -
09/30/25 - 6.75
06/30/25 - 7.77
ROA
12/31/25 - -
09/30/25 - 5.83
06/30/25 - 6.75
Current Ratio
12/31/25 - -
09/30/25 - 8.36
06/30/25 - 6.57
Quick Ratio
12/31/25 - -
09/30/25 - 6.40
06/30/25 - 4.90
Operating Margin
12/31/25 - -
09/30/25 - 6.25
06/30/25 - 7.00
Net Margin
12/31/25 - -
09/30/25 - 6.25
06/30/25 - 7.00
Pre-Tax Margin
12/31/25 - -
09/30/25 - 6.27
06/30/25 - 6.98
Book Value
12/31/25 - -
09/30/25 - 0.80
06/30/25 - 0.78
Inventory Turnover
12/31/25 - -
09/30/25 - 1.87
06/30/25 - 1.76
Debt-to-Equity
12/31/25 - -
09/30/25 - 0.00
06/30/25 - 0.00
Debt-to-Capital
12/31/25 - -
09/30/25 - 0.00
06/30/25 - 0.00
 

Powered by Zacks Investment Research ©